Topical Emulsion Stabilizes Stilbene via Antioxidant and Inert Environment

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Formulating a topical pharmaceutical composition that is both physically and chemically stable, non-irritating to the skin, and effectively delivers 3,5-Dihydroxy-4-isopropyl-trans-stilbene to treat dermatological conditions while minimizing systemic exposure.

Innovation Solution

A topical pharmaceutical emulsion composition comprising 3,5-Dihydroxy-4-isopropyl-trans-stilbene, a pharmaceutically acceptable salt, an oil phase, a water phase, a surfactant, and an antioxidant, with the active ingredient solubilized in the oil phase, using mineral oil and/or petrolatum with additional oil phase components like esters of glycerin to create a homogeneous and stable emulsion.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If 3,5-Dihydroxy-4-isopropyl-trans-stilbene is formulated in a topical composition, then dermatological treatment efficacy is improved, but chemical stability deteriorates due to oxidation and photo degradation sensitivity

Engineering Contradiction:
Improvetreatment efficacyVSAvoidchemical stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent introduces an antioxidant as an intermediary substance that protects the active ingredient 3,5-Dihydroxy-4-isopropyl-trans-stilbene from oxidation. The antioxidant acts as a mediator between the active ingredient and environmental oxidants, preventing degradation while allowing the active ingredient to maintain its therapeutic efficacy.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates a protective environment for the light-sensitive active ingredient by incorporating photo stabilizers and selecting appropriate container materials that block UV light. This inert environment prevents photo degradation, allowing the active ingredient to remain stable while maintaining treatment effectiveness.

Inventive Principle:
Principle #39Inert atmosphere (Inert environment)

2Reliability

If the active ingredient is delivered to the skin to treat dermatological conditions, then therapeutic effect is improved, but skin irritation increases

Engineering Contradiction:
Improvetherapeutic effectVSAvoidskin irritation
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent modifies the formulation parameters by adjusting the pH to skin-compatible levels, optimizing the concentration of the active ingredient, and selecting appropriate excipients that are non-irritating. These parameter changes allow effective delivery of the active ingredient while minimizing skin irritation and improving tolerability.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If the composition is designed to penetrate skin layers, then delivery efficacy is improved, but physical stability deteriorates

Engineering Contradiction:
Improvedelivery efficacyVSAvoidphysical stability
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent employs a composite formulation combining multiple excipients with different functions: emulsifiers to stabilize the mixture, penetration enhancers to facilitate skin penetration, and vehicle components that provide physical stability. This composite approach allows the composition to achieve both effective skin penetration and physical stability during storage and application.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composition achieves stable skin delivery of 3,5-Dihydroxy-4-isopropyl-transilbene with improved skin penetration and reduced systemic exposure, maintaining homogeneity and stability over time.

Implementation Method 1

3,5-Dihydroxy-4-isopropyl-trans-stilbene is known to be sensitive to oxidation and photo degradation

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

a surfactant, and an antioxidant, with the active ingredient solubilized in the oil phase

Methodology Applied
Scientific EffectSurfactant: Surfactant

Implementation Method 3

the active ingredient solubilized in the oil phase

Methodology Applied
Scientific EffectSolubilization: Solvation

Data Source

PatentUS20230126208A1Topical pharmaceutical compositions
Publication Date: 2023.04.27 DERMAVANT SCI GMBH
  • US20230126208A1 patent drawing
  • US20230126208A1 patent drawing
  • US20230126208A1 patent drawing

AI summary

The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.